Cargando…
Full-dose NSAIDs at the first sign of respiratory infection?
Autor principal: | Donzelli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605611/ https://www.ncbi.nlm.nih.gov/pubmed/36309020 http://dx.doi.org/10.1016/S1473-3099(22)00649-1 |
Ejemplares similares
-
Full-dose NSAIDs at the first sign of respiratory infection? – Authors’ reply
por: Ruggenenti, Piero, et al.
Publicado: (2022) -
Conflicting COVID-19 excess mortality estimates
por: Donzelli, Alberto
Publicado: (2023) -
Prospective role of NSAIDs with antiviral properties for pharmacological management of postsurgical procedures during COVID-19
por: Nainu, Firzan, et al.
Publicado: (2023) -
Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data
por: Bellavite, Paolo, et al.
Publicado: (2021) -
Localized Pustular Purpuric Eruption Associated with Propionic Acid NSAIDs: Acute Localized Exanthematous Pustulosis Accompanied with Leukocytoclastic Vasculitis
por: Baba, Yuko, et al.
Publicado: (2022)